UBS Group
WGRX

UBS Group’s Wellgistics Health WGRX Stock Holding History

UBS Group’s Portfolio WGRX Stock Details WGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-319
Closed -$6.37K – 11527
2025
Q4 		$6.37K Sell
319
-534
-63% -$15.7K ﹤0.01% 8559
2025
Q3 		$37.8K Buy
+853
New +$45K ﹤0.01% 7758
2025
Q2 		– Sell
-59
Closed -$12.8K – 11118
2025
Q1 		$12.8K Buy
+59
New +$9.95K ﹤0.01% 8479

Other funds holding WGRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

UBS Group's WGRX Position: Q1 2026 in Review

UBS Group sold out of Wellgistics Health (WGRX) in Q1 2026, closing a stake of 319 shares — an estimated $6.37K sold.

UBS Group first reported a position in WGRX in Q1 2025 and held it in 3 quarters. The position peaked at $37.8K in Q3 2025. 13 funds tracked by Wall St. Rank hold WGRX as of Q1 2026.

  • UBS Group reported no remaining Wellgistics Health position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 319 Wellgistics Health shares in Q1 2026, an estimated $6.37K.
  • UBS Group first reported a position in Wellgistics Health in Q1 2025 and held it in 3 quarters.
  • UBS Group's Wellgistics Health position peaked at $37.8K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held Wellgistics Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.